SK2094A3 - Somatostatine polypeptides, method of their preparing and using - Google Patents

Somatostatine polypeptides, method of their preparing and using Download PDF

Info

Publication number
SK2094A3
SK2094A3 SK20-94A SK2094A SK2094A3 SK 2094 A3 SK2094 A3 SK 2094A3 SK 2094 A SK2094 A SK 2094A SK 2094 A3 SK2094 A3 SK 2094A3
Authority
SK
Slovakia
Prior art keywords
group
residue
carbon atoms
formula
nuclide
Prior art date
Application number
SK20-94A
Other languages
English (en)
Slovak (sk)
Inventor
Rainer Albert
Helmut Macke
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939300510A external-priority patent/GB9300510D0/en
Priority claimed from GB939313129A external-priority patent/GB9313129D0/en
Priority claimed from GB939315561A external-priority patent/GB9315561D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SK2094A3 publication Critical patent/SK2094A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SK20-94A 1993-01-12 1994-01-10 Somatostatine polypeptides, method of their preparing and using SK2094A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939300510A GB9300510D0 (en) 1993-01-12 1993-01-12 Improvements in or relating to organic compounds
GB939313129A GB9313129D0 (en) 1993-06-24 1993-06-24 Improvements in or relating to organic compounds
GB939315561A GB9315561D0 (en) 1993-07-28 1993-07-28 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
SK2094A3 true SK2094A3 (en) 1995-01-12

Family

ID=27266539

Family Applications (1)

Application Number Title Priority Date Filing Date
SK20-94A SK2094A3 (en) 1993-01-12 1994-01-10 Somatostatine polypeptides, method of their preparing and using

Country Status (11)

Country Link
EP (1) EP0607103A3 (de)
JP (1) JPH06234792A (de)
KR (1) KR940018397A (de)
CA (1) CA2113121A1 (de)
CZ (1) CZ5594A3 (de)
FI (1) FI940109A7 (de)
HU (1) HUT66294A (de)
IL (1) IL108308A0 (de)
NO (1) NO940080L (de)
NZ (1) NZ250653A (de)
SK (1) SK2094A3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
AU689626B2 (en) 1994-07-25 1998-04-02 Boehringer Mannheim Gmbh Peptides marked with metal chelates
GB9417873D0 (en) 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
US6331285B1 (en) 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
JP2001513114A (ja) * 1997-11-24 2001-08-28 ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ 放射性同位元素標識した化合物の組織への蓄積を促進するための方法
US7385025B2 (en) 2000-12-19 2008-06-10 Palatin Technologies, Inc. Metallopeptide compounds
ITMI20011708A1 (it) * 2001-08-03 2003-02-03 Bracco Imaging Spa Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
JP2025532104A (ja) 2022-09-23 2025-09-29 ヌクリディウム アクチェンゲゼルシャフト 高純度銅放射性医薬組成物ならびにその診断および治療用途
TW202426433A (zh) 2022-09-23 2024-07-01 瑞士商紐利迪姆股份公司 成纖維細胞活化蛋白（ｆａｐ）抑制劑、ｆａｐ結合物及其診斷與治療用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0607103A2 (de) 1994-07-20
FI940109L (fi) 1994-10-11
EP0607103A3 (de) 1997-07-09
IL108308A0 (en) 1994-04-12
NO940080D0 (no) 1994-01-10
HUT66294A (en) 1994-11-28
JPH06234792A (ja) 1994-08-23
CA2113121A1 (en) 1994-07-13
FI940109A0 (fi) 1994-01-10
FI940109A7 (fi) 1994-10-11
NZ250653A (en) 1995-12-21
NO940080L (no) 1994-07-13
AU678778B2 (en) 1997-06-12
KR940018397A (ko) 1994-08-16
HU9400058D0 (en) 1994-05-30
CZ5594A3 (en) 1994-07-13
AU5309394A (en) 1994-07-21

Similar Documents

Publication Publication Date Title
US5650134A (en) Peptides
JP3686503B2 (ja) ペプチド誘導体
KR100364111B1 (ko) 소마토스타틴펩타이드,이의제법및이를함유하는약학적조성물
EP0831938B1 (de) Mittel auf basis radiomarkierter peptide zur ortsspezifischen verabreichung
SK2094A3 (en) Somatostatine polypeptides, method of their preparing and using
JP3397338B2 (ja) ポリペプチド類
US5776894A (en) Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
CA3245281A1 (en) Compound targeting sstr2, preparation method therefor and use thereof
US6551574B2 (en) Tuftsin metallopeptide analogs and uses thereof
JP6410339B2 (ja) 放射性核種標識オクトレオチド誘導体
EP0700930B1 (de) Peptide mit Affinität zu Tumoren und diese enthaltende radioaktive diagnostische und therapeutische Zusammensetzungen
JP4318985B2 (ja) ソマトスタチンアナログ誘導体およびその利用
IE920357A1 (en) Msh peptide derivatives
IT8922642A1 (it) Derivati da peptidi della somatostatina che portano almeno un gruppo chelante per un elemento rilevabile.